Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro DiagnosticsPOC Diagnostics

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1211987

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1211987

Point-of-Care/Rapid Diagnostics

PUBLISHED:
PAGES: 159 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5450
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 16350

Add to Cart

Description

Table of Contents

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Point-of-Care/Rapid Diagnostics Market to Reach $46.4 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Point-of-Care/Rapid Diagnostics estimated at US$25.3 Billion in the year 2022, is projected to reach a revised size of US$46.4 Billion by 2030, growing at a CAGR of 7.9% over the analysis period 2022-2030. Glucose Monitoring Products, one of the segments analyzed in the report, is projected to record a 8.6% CAGR and reach US$12.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Cardiometabolic Testing Products segment is readjusted to a revised 8.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $6.9 Billion, While China is Forecast to Grow at 11.4% CAGR

The Point-of-Care/Rapid Diagnostics market in the U.S. is estimated at US$6.9 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$10 Billion by the year 2030 trailing a CAGR of 11.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.6% and 6.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$6.6 Billion by the year 2030.

Select Competitors (Total 13 Featured):

  • Abbott Laboratories
  • AccuBioTech Co., Ltd.
  • Becton, Dickinson and Company
  • Chembio Diagnostic Systems, Inc.
  • Danaher Corporation
  • EKF Diagnostics Holdings PLC
  • Instrumentation Laboratory
  • Johnson & Johnson
  • Nova Biomedical Corporation
  • PTS Diagnostics
  • Quidel Corporation
  • Roche Diagnostics (Schweiz) AG
  • Sekisui Diagnostics LLC
  • Siemens AG
  • Trinity Biotech PLC
Show more
Product Code: MCP14041

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Point-Of-Care/Rapid Diagnostics: Overview & Outlook
    • Point-of-Care/Rapid Diagnostics - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Emphasis on Decentralized Testing & Laboratory Strengthening Programs Augurs Well
    • Emergency Departments Rely on Rapid POC Diagnostics
    • Rapid POC Diagnostics Streamline Urgent Cardiac Care Settings
    • Rapid POC Diagnostics Gain Traction in Diagnosis of STD
    • Rapid POC Diagnostics for Tuberculosis Diagnosis
    • Quality Assurances Accelerate Adoption
    • Issues & Challenges
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Point-of-Care/Rapid Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Glucose Monitoring Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Glucose Monitoring Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Glucose Monitoring Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Cardiometabolic Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Cardiometabolic Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Cardiometabolic Testing Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Infectious Disease Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Infectious Disease Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Infectious Disease Testing Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Coagulation Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Coagulation Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Coagulation Testing Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pregnancy & Fertility Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Pregnancy & Fertility Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Pregnancy & Fertility Testing Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Tumor/Cancer Marker Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Tumor/Cancer Marker Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Tumor/Cancer Marker Testing Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Urinalysis Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Urinalysis Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Urinalysis Testing Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Cholesterol Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Cholesterol Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 27: World 16-Year Perspective for Cholesterol Testing Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Hematology Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Hematology Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 30: World 16-Year Perspective for Hematology Testing Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Drugs-of-Abuse Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Drugs-of-Abuse Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 33: World 16-Year Perspective for Drugs-of-Abuse Testing Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Fecal Occult Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Fecal Occult Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 36: World 16-Year Perspective for Fecal Occult Testing Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Other POC Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Other POC Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 39: World 16-Year Perspective for Other POC Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for OTC-based Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 41: World Historic Review for OTC-based Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 42: World 16-Year Perspective for OTC-based Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 43: World Recent Past, Current & Future Analysis for Prescription-based Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 44: World Historic Review for Prescription-based Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 45: World 16-Year Perspective for Prescription-based Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 46: World Recent Past, Current & Future Analysis for Lateral Flow Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 47: World Historic Review for Lateral Flow Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 48: World 16-Year Perspective for Lateral Flow Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 49: World Recent Past, Current & Future Analysis for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 50: World Historic Review for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 51: World 16-Year Perspective for Dipsticks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 52: World Recent Past, Current & Future Analysis for Microfluidics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 53: World Historic Review for Microfluidics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 54: World 16-Year Perspective for Microfluidics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 55: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 56: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 57: World 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 58: World Recent Past, Current & Future Analysis for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 59: World Historic Review for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 60: World 16-Year Perspective for Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 61: World Point-of-Care/Rapid Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Point-of-Care/Rapid Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 62: USA Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: USA Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: USA 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2023 & 2030
    • TABLE 65: USA Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: USA Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: USA 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2023 & 2030
    • TABLE 68: USA Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: USA Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: USA 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: Canada 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2023 & 2030
    • TABLE 74: Canada Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Canada Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: Canada 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2023 & 2030
    • TABLE 77: Canada Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Canada Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: Canada 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2023 & 2030
  • JAPAN
    • Point-of-Care/Rapid Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 80: Japan Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Japan Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: Japan 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2023 & 2030
    • TABLE 83: Japan Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: Japan 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2023 & 2030
    • TABLE 86: Japan Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Japan Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: Japan 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2023 & 2030
  • CHINA
    • Point-of-Care/Rapid Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 89: China Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: China Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: China 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2023 & 2030
    • TABLE 92: China Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: China Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: China 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2023 & 2030
    • TABLE 95: China Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: China Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: China 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2023 & 2030
  • EUROPE
    • Point-of-Care/Rapid Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Point-of-Care/Rapid Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: Europe 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: Europe 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2023 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: Europe 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2023 & 2030
    • TABLE 107: Europe Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Europe Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 109: Europe 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2023 & 2030
  • FRANCE
    • Point-of-Care/Rapid Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 110: France Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 112: France 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2023 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 115: France 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2023 & 2030
    • TABLE 116: France Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: France Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 118: France 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2023 & 2030
  • GERMANY
    • Point-of-Care/Rapid Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 121: Germany 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2023 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 124: Germany 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2023 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 127: Germany 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 130: Italy 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2023 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 133: Italy 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2023 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 136: Italy 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Point-of-Care/Rapid Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 137: UK Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 139: UK 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2023 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 142: UK 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2023 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 145: UK 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2023 & 2030
  • SPAIN
    • TABLE 146: Spain Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Spain Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 148: Spain 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2023 & 2030
    • TABLE 149: Spain Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Spain Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 151: Spain 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2023 & 2030
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 154: Spain 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2023 & 2030
  • RUSSIA
    • TABLE 155: Russia Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Russia Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 157: Russia 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2023 & 2030
    • TABLE 158: Russia Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Russia Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 160: Russia 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2023 & 2030
    • TABLE 161: Russia Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 162: Russia Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 163: Russia 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 164: Rest of Europe Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 165: Rest of Europe Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 166: Rest of Europe 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2023 & 2030
    • TABLE 167: Rest of Europe Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 168: Rest of Europe Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 169: Rest of Europe 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2023 & 2030
    • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 171: Rest of Europe Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 172: Rest of Europe 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Point-of-Care/Rapid Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 173: Asia-Pacific Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 174: Asia-Pacific Historic Review for Point-of-Care/Rapid Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 175: Asia-Pacific 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
    • TABLE 176: Asia-Pacific Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 177: Asia-Pacific Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 178: Asia-Pacific 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2023 & 2030
    • TABLE 179: Asia-Pacific Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 180: Asia-Pacific Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 181: Asia-Pacific 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2023 & 2030
    • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Asia-Pacific Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 184: Asia-Pacific 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2023 & 2030
  • AUSTRALIA
    • Point-of-Care/Rapid Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 185: Australia Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 186: Australia Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 187: Australia 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2023 & 2030
    • TABLE 188: Australia Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 189: Australia Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 190: Australia 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2023 & 2030
    • TABLE 191: Australia Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 192: Australia Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 193: Australia 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2023 & 2030
  • INDIA
    • Point-of-Care/Rapid Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 194: India Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 195: India Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 196: India 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2023 & 2030
    • TABLE 197: India Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 198: India Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 199: India 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2023 & 2030
    • TABLE 200: India Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 201: India Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 202: India 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2023 & 2030
  • SOUTH KOREA
    • TABLE 203: South Korea Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 204: South Korea Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 205: South Korea 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2023 & 2030
    • TABLE 206: South Korea Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 207: South Korea Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 208: South Korea 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2023 & 2030
    • TABLE 209: South Korea Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 210: South Korea Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 211: South Korea 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 212: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 213: Rest of Asia-Pacific Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 214: Rest of Asia-Pacific 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2023 & 2030
    • TABLE 215: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 216: Rest of Asia-Pacific Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 217: Rest of Asia-Pacific 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2023 & 2030
    • TABLE 218: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 219: Rest of Asia-Pacific Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 220: Rest of Asia-Pacific 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2023 & 2030
  • LATIN AMERICA
    • Point-of-Care/Rapid Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 221: Latin America Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 222: Latin America Historic Review for Point-of-Care/Rapid Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 223: Latin America 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
    • TABLE 224: Latin America Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 225: Latin America Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 226: Latin America 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2023 & 2030
    • TABLE 227: Latin America Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 228: Latin America Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 229: Latin America 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2023 & 2030
    • TABLE 230: Latin America Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 231: Latin America Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 232: Latin America 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2023 & 2030
  • ARGENTINA
    • TABLE 233: Argentina Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 234: Argentina Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 235: Argentina 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2023 & 2030
    • TABLE 236: Argentina Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 237: Argentina Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 238: Argentina 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2023 & 2030
    • TABLE 239: Argentina Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 240: Argentina Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 241: Argentina 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2023 & 2030
  • BRAZIL
    • TABLE 242: Brazil Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 243: Brazil Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 244: Brazil 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2023 & 2030
    • TABLE 245: Brazil Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 246: Brazil Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 247: Brazil 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2023 & 2030
    • TABLE 248: Brazil Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 249: Brazil Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 250: Brazil 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2023 & 2030
  • MEXICO
    • TABLE 251: Mexico Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 252: Mexico Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 253: Mexico 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2023 & 2030
    • TABLE 254: Mexico Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 255: Mexico Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 256: Mexico 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2023 & 2030
    • TABLE 257: Mexico Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 258: Mexico Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 throu
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!